PREDICT (Patient characteristics in Renal cell carcinoma and Daily practice Treatment with Nexavar) global non-interventional study: first interim results

被引：0
|
作者：
Jager, D. [1 ]
Ma, J. H. [2 ]
Korbenfeld, E. [3 ]
Zemanova, M. [4 ]
Leonhartsberger, N. [5 ]
Stauch, K. [6 ]
Boeckenhoff, A. [7 ]
Yu, J. [8 ]
Escudier, B. [9 ]
机构：
[1] Univ Heidelberg, Natl Ctr Tumor Dis, Heidelberg, Germany
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina
[4] Charles Univ Prague, Prague, Czech Republic
[5] Univ Innsbruck, A-6020 Innsbruck, Austria
[6] Bayer HealthCare, Leverkusen, Germany
[7] Bayer HealthCare, Wuppertal, Germany
[8] Bayer HealthCare, Montville, NJ USA
[9] Inst Gustave Roussy, Villejuif, France
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71461-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：431 / 432
页数：2
相关论文
共 50 条
  • [41] Final Results of a Non-Interventional Study Evaluating the Quality of Life in Second-line Treatment of Metastatic Renal Cell Carcinoma With Everolimus: The EVERPRO Study
    Goebell, Peter J.
    Hermann, Edwin
    Kube, Ulrich
    Doehn, Christian
    Marschner, Norbert
    Dietel, Anja
    Blumenstengel, Katja
    Grimm, Marc-Oliver
    Scheffler, Michael
    Rogler, Anja
    Bergmann, Lothar
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (1-2) : 57 - 66
  • [42] First interim analysis of the GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib) non-interventional study (vol 66, pg 675, 2012)
    Ladron de Guevara, L.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (09) : 912 - 912
  • [43] First interim analysis of the German prospective, non-interventional study PaVe: first results on the clinical routine of ruxolitinib in polycythemia vera
    Griesshammer, M.
    von der Heyde, E.
    Weide, R.
    Reichert, D.
    Weniger, J.
    Schlag, R.
    Hutzschenreuter, U.
    Becker, M.
    Just, M.
    Hacker, E.
    Cavanna, D.
    Lengfelder, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 148 - +
  • [44] Results of a pre-planned interim analysis of a non-interventional study of everolimus after failure of the first anti-VEGF therapy in metastatic renal cell carcinom
    Jakob, A.
    Kube, U.
    Kindler, M.
    Koepke, T.
    Janssen, J.
    Goebell, P. -J.
    Schulze, M.
    Schmitz, J.
    Stern, S.
    Overkamp, F.
    Staehler, M.
    Steiner, T.
    Doehn, C.
    Albrecht, M.
    Guderian, G.
    Bergmann, L.
    ONKOLOGIE, 2011, 34 : 180 - 180
  • [45] Sorafenib Treatment of Advanced Renal Cell Carcinoma Patients in Daily Practice: The Large International PREDICT Study
    Jaeger, D.
    Ma, J. H.
    Mardiak, J.
    Ye, D. W.
    Korbenfeld, E.
    Zemanova, M.
    Ahn, H.
    Guo, J.
    Leonhartsberger, N.
    Stauch, K.
    Boeckenhoff, A.
    Yu, J.
    Escudier, B.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (02) : 156 - 164
  • [46] A national, multicenter, non-interventional, observational study on treatment patterns in patients with metastatic renal cell carcinoma in Turkey - NOTES study
    Yalcin, Suayib
    Yildiz, Ramazan
    Dane, Faysal
    Karaoglu, Aziz
    Oksuzoglu, Berna
    Ozyilkan, Ozgur
    Sevinc, Alper
    Ozdemir, Feyyaz
    Turna, Hande
    Uslu, Ruchan
    Ulay, Esat
    ONCOTARGETS AND THERAPY, 2018, 11 : 1223 - 1228
  • [47] Patients switching to fingolimod in daily clinical routine: 2 year interim results from the non-interventional study PANGAEA 2.0
    Schulze-Topphoff, U.
    Ettle, B.
    Cornelissen, C.
    Ziemssen, T.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 932 - 932
  • [48] Olaparib routine clinical practice in Germany - Quality of life interim results of the non-interventional C-PATROL study
    El-Balat, A.
    Marme, F.
    Sehouli, J.
    Welslau, M.
    Grabowski, J. P.
    Hartkopf, A.
    Glowik, R.
    Hilpert, F.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2020, 80 (10) : E188 - E188
  • [49] German hematologists/oncologists' practice patterns for prophylaxis and treatment of venous thromboembolism in cancer patients - first results of a non-interventional study
    Matzdorff, A.
    Ledig, B.
    Stuecker, M.
    Riess, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 216 - 216
  • [50] CaboCombo: A prospective international non-interventional study of first-line cabozantinib plus nivolumab for the treatment of patients with advanced renal cell carcinoma.
    Barthelemy, Philippe
    Dutailly, Pascale
    Qvick, Bryan
    Perrot, Valerie
    Verzoni, Elena
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345